Nplate 500 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBW6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,051
Award facts
- Contract value 100% obligated
- $24,050.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,050.58 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 500 microgram vials of Nplate. The award was issued on January 14, 2026, with an ultimate completion date of February 5, 2026, and utilized no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors that supply a comprehensive range of pharmaceutical products to support Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical supply chain, with the parent PPV-G GEN V contract (SPE2DR) awarded on November 13, 2025, featuring a $499,999,999 ceiling value and completion date of December 31, 2036. The contractor's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill the diverse pharmaceutical requirements of DoD healthcare operations globally. The contractor holds no identified subcontractor relationships and has demonstrated substantial federal contracting activity through multiple delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FFBW6?
SPE2DR26FFBW6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FFBW6 worth?
The government has obligated $24,051 on SPE2DR26FFBW6.
Is contract SPE2DR26FFBW6 an order under another contract?
Yes. SPE2DR26FFBW6 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBW6 competed?
The extent of competition for SPE2DR26FFBW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award